By Dr. Marianne Weber, Dr. Stephen Wade & Prof. Karen Canfell
In this article, we summarize the findings of our recent cost-effectiveness evaluation of lung cancer screening with low-dose computed tomography (LDCT) [1] in which we applied Australian health services costs and population based survival data to the outcomes observed in the U.S.
Read More:Â Lung Cancer Weber Wade Canfell FebMarch2019